High-resolution, multiparametric (anatomical, functional and dynamic) MR Imaging of the breast on a patient with ductal carcinoma of no special type.
Initial results regarding MRI of the breast were published more than 30 years ago, but clinical use started during the 1990s after the introduction of contrast-enhanced protocols. Breast MRI is today one of the main methods for diagnosing breast diseases, together with mammography, ultrasound and image-guided needle biopsy. Breast MRI should be performed using 1.5 or 3 Tesla MRI systems and can well differentiate lesions and abnormalities of the breast. However, in order to diagnose or exclude a cancer, intravenous administration of a gadolinium-based contrast agent (GBCA) is needed. Injection of a GBCA is not required for the evaluation of breast implant integrity.
In terms of cancer detection, MRI outperforms (but not entirely substitutes) both mammography and ultrasound. Its valuable diagnostic performance has been confirmed by many studies. However, MRI also detects benign lesions that would otherwise have gone unnoticed, leading to additional otherwise unnecessary work-up.
#radiologyedu #myradiologyedu #radiologyeducation #myradiologyeducation #radiology #myradiology #MRI #breast #NST #ductalcarcinoma